King's College London

Research portal

Ethics of regulating competition for women with hyperandrogenism

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)293-301
Number of pages15
JournalClinics in Sports Medicine
Early online date26 Nov 2015
DOIs
E-pub ahead of print26 Nov 2015
Published1 Jan 2016

Documents

  • CH0002_Camporesi_v3

    CH0002_Camporesi_v3.docx, 116 KB, application/vnd.openxmlformats-officedocument.wordprocessingml.document

    Uploaded date:05 Mar 2016

    Version:Accepted author manuscript

King's Authors

Abstract

KEY POINTS
1. IAAF Hyperandrogenism Regulations are flawed on a scientific level because it has not been proved that testosterone confers an advantage in competition.
2. IAAF Hyperandrogenism Regulations raise issues of consistencies on two levels: other molecular and genetic variations that confer an advantage in competition are not considered unfair; and there is no upper limit for testosterone in the male category.
3. IAAF Hyperandrogenism Regulations raise ethical issues at the level of implementation because the trigger for testing is visual perception and hence they pressure female athletes into conforming to stereotypical feminine standards.
4. IAAF Hyperandrogenism Regulations raise medical concerns because they unnecessarily medicalize a condition (hyperandrogenism) in female athletes with long-term side effects.
5. We need to be critical of the grounds on which the Court of Arbitration for Sport (CAS) has suspended the IAAF Hyperandrogenism Regulations on July 27, 2015, because CAS is buying into the IAAF flawed assumption that if there were a sufficient body of evidence to demonstrate a correlation between testosterone and competitive advantage, this would be unfair and would constitute grounds to reinstate the hyperandrogenism regulations.

Download statistics

No data available

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454